Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 9/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7851966 | 0.93 | FFAR1 (0.37) | ACACB | |
| SCHEMBL7859001 | 0.90 | ACACB (0.37) | ACACB | |
| SCHEMBL7858833 | 0.88 | ESR2 (0.32) | ACACB | |
| SCHEMBL6141749 | 0.87 | ESR2 (0.31) | ACACB | |
| SCHEMBL6141833 | 0.86 | ACACB (0.35) | ACACB | |
| SCHEMBL7852001 | 0.86 | ACACB (0.35) | ACACB | |
| SCHEMBL6142012 | 0.85 | P2RY14 (0.32) | — | |
| SCHEMBL6141733 | 0.85 | — | — | |
| SCHEMBL6141675 | 0.84 | FFAR1 (0.39) | ACACB | |
| SCHEMBL7851988 | 0.83 | ACACB (0.35) | ACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0930286-B1 | LIQUID-CRYSTAL ALKENYLTOLAN DERIVATIVE, LIQUID-CRYSTAL COMPOSITION, AND LIQUID-CRYSTAL DISPLAY ELEMENT | CHISSO CORP (JP) | 2005-01-12 | — | — | EP | disclosed |
| US-6333080-B1 | HIGH ANISOTROPY, HIGH ELASTIC CONSTANT RATIO, EXCELLENT COMPARABILITY WITH OTHER LIQUID-CRYSTAL COMPOUNDS, AND LOW VISCOSITY AND ARE CHEMICALLY AND PHYSICALLY STABLE | CHISSO CORPORATION (JP) | 2001-12-25 | — | — | US | disclosed |
| EP-0930286-A1 | LIQUID-CRYSTAL ALKENYLTOLAN DERIVATIVE, LIQUID-CRYSTAL COMPOSITION, AND LIQUID-CRYSTAL DISPLAY ELEMENT | CHISSO CORPORATION (JP) | 1999-07-21 | — | — | EP | disclosed |